REAL-WORLD DISTRIBUTION OF HEMATOCRIT VALUES IN CZECH REPUBLIC, NETHERLANDS AND SOUTH AFRICA SUGGESTS THAT HEMATOCRIT INTERFERENCE IS MORE COMMON THAN USUALLY ASSUMED

被引:0
|
作者
Hinzmann, R. [1 ]
Militz, D. [1 ]
Hauss, O. [2 ]
Storm, H. [3 ]
Spacek, M. [4 ,5 ]
Chapanduka, Z. [6 ,7 ]
Zima, T. [4 ,5 ]
机构
[1] Roche Diabet Care GmbH, Global Med & Sci Affairs, Mannheim, Germany
[2] Dr Hauss Training & Beratung, Maxdorf, Germany
[3] CERTE, Locatie Med Ctr Leeuwarden, Leeuwarden, Netherlands
[4] Charles Univ Prague, Fac Med 1, Inst Med Chem & Lab Med, Prague, Czech Republic
[5] Gen Univ Hosp, Prague, Czech Republic
[6] Stellenbosch Univ, Cape Town, South Africa
[7] NHLS Tygerberg Hosp, Dept Pathol, Cape Town, South Africa
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
809
引用
下载
收藏
页码:A134 / A134
页数:1
相关论文
共 3 条
  • [1] Real-World Distribution of Hematocrit Values in the Netherlands and the Czech Republic-A Cross-Sectional Study
    Zima, Tomas
    Storm, Huibert
    Spacek, Martin
    Wardat, Sami
    Hauss, Oliver
    Hinzmann, Rolf
    DIABETES, 2018, 67
  • [2] Real-World Evidence From More Than 1000 Patients Treated With Adalimumab For Moderate-to-Severe Psoriasis in the Czech Republic
    Martina Kojanova
    Petra Cetkovska
    Daniela Strosova
    Jorga Fialova
    Petr Arenberger
    Tomas Dolezal
    Spyridon Gkalpakiotis
    Dermatology and Therapy, 2021, 11 : 543 - 553
  • [3] Real-World Evidence From More Than 1000 Patients Treated With Adalimumab For Moderate-to-Severe Psoriasis in the Czech Republic
    Kojanova, Martina
    Cetkovska, Petra
    Strosova, Daniela
    Fialova, Jorga
    Arenberger, Petr
    Dolezal, Tomas
    Gkalpakiotis, Spyridon
    DERMATOLOGY AND THERAPY, 2021, 11 (02) : 543 - 553